Testing Messages to Promote HPV Vaccination

Status Completed

Clinical Trial Summary

Human papillomavirus (HPV) is the most common sexually transmitted infection worldwide. Hispanic women have the highest rates of HPV-related cervical cancer compared to all other groups in the U.S. Previous research has delineated several unique barriers to HPV vaccination among Hispanic women, suggesting that interventions that focus on addressing these barriers may improve HPV vaccination compliance in this population. To address some of these unique barriers, an online tailored messaging intervention was developed and tested. Initial analyses demonstrate that participants exposed to an online intervention demonstrated higher intentions to vaccinate for HPV after viewing the informational materials. The next phase of the project will be comprised of promoting use of the online intervention to the general public through the use of theory-based, pretested messages delivered via advertisements on Facebook and Twitter. Specifically, messages will be targeted based on differences between Hispanic parents of adolescents and Hispanic young adults. Previous research has explored the use of the Extended Parallel Processing Model as a theory to guide messages designed to promote health behaviors. The current study extends this work in the area of HPV prevention. Specifically, it seeks to examine the use of this theory as a means to stimulate information seeking behavior in the form of use of the previously developed online intervention that provides information about HPV. We also hope to make a significant contribution to research demonstrating the importance of targeting messages based on differences in population characteristics. Additionally, this study seeks to build on research examining the use of social media sites as a means for implementing health interventions and promoting positive health outcomes. Ultimately, the current study seeks to improve both the HPV vaccination decision-making process and HPV vaccination rates. If this was achieved among the Hispanic population it could substantially decrease disparities in cervical cancer and other HPV-related diseases.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05206669
Study type	Interventional
Source	University of Colorado, Denver
Contact
Status	Completed
Phase	N/A
Start date	November 18, 2016
Completion date	March 5, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05994820` - Chatbot-based Intervention to Promote Vaccine Acceptance in Varansi, India	N/A
Completed	`NCT05537441` - Precision Vaccine Promotion in Underserved Populations	N/A
Recruiting	`NCT05998824` - COVID-19 Vaccination Hesitancy in Adults With Sickle Cell Disease	N/A
Terminated	`NCT05167422` - Trusted Messenger Intervention	N/A
Completed	`NCT04939506` - COVID-19 Vaccine Education at the Point of Testing to Increase Vaccine Uptake in Vulnerable Communities in SE Louisiana	N/A
Recruiting	`NCT05787015` - Testing a Personalized Normative Feedback Intervention for Vaccine Hesitancy	N/A
Enrolling by invitation	`NCT06062056` - Motivational Interviewing for Vaccine Uptake in Latinx Adults	N/A
Recruiting	`NCT05473936` - A CHW Intervention to Identify and Decrease Barriers to COVID 19 Testing & Vaccination	N/A
Not yet recruiting	`NCT05531058` - The Impact of a Web-based Psychoeducation Programme With a Motivational AI Chatbot on Covid-19 Vaccine Hesitancy	N/A
Not yet recruiting	`NCT05120817` - Emphasizing the Personal Versus the Social in Educational Interventions For Decreasing Vaccine Hesitancy	N/A
Completed	`NCT06155877` - Testing The Effectiveness Of Two Interventions To Reduce Vaccine Hesitancy Among Adolescents	N/A
Completed	`NCT06124131` - Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening	N/A
Recruiting	`NCT06417762` - Dime La VerDAD: Verify, Debunk, and Disseminate	N/A
Recruiting	`NCT06297876` - COVIDVaxStories: Randomized Trial to Reduce COVID-19 Vaccine Hesitancy in Populations of Color	N/A
Enrolling by invitation	`NCT06156228` - Multilevel Intervention of COVID-19 Vaccine Uptake Among Latinos	N/A
Recruiting	`NCT05042011` - Role of mHealth-based Interventions Including Social Media to Improve Childhood Immunization Coverage During COVID 19 Pandemic in Pakistan: Qualitative Study
Not yet recruiting	`NCT06374134` - The Impact of Community and Patient Engagement Practices on Vaccine Confidence in the United States
Completed	`NCT01385501` - Educational Intervention to Improve Vaccine Acceptance	N/A
Completed	`NCT05582564` - The Effect of Newspaper Reporting on COVID-19 Vaccine Hesitancy: a Randomised Controlled Trial	N/A
Completed	`NCT05390697` - Educational Videos to Address Vaccine Hesitancy in Childhood Immunization	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.